NCT06681818 Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
| NCT ID | NCT06681818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Englewood Hospital and Medical Center |
| Condition | Liver Cancer Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 125 participants |
| Start Date | 2025-11-21 |
| Primary Completion | 2039-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 125 participants in total. It began in 2025-11-21 with a primary completion date of 2039-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.
Eligibility Criteria
Inclusion Criteria: * Patient plans to have partial liver resection for primary liver pathology or metastatic disease * Patient is able to comprehend and willing to sign the written consent form Exclusion Criteria: * Patients \< 18 years * Patients identified as members of a vulnerable population, except women of child bearing potential with negative pregnancy test
Contact & Investigator
Cherif Boutros, MD
PRINCIPAL INVESTIGATOR
Englewood Hospital
Frequently Asked Questions
Who can join the NCT06681818 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Cancer Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06681818 currently recruiting?
Yes, NCT06681818 is actively recruiting participants. Contact the research team at jamie.ketas@ehmchealth.org for enrollment information.
Where is the NCT06681818 trial being conducted?
This trial is being conducted at Englewood, United States.
Who is sponsoring the NCT06681818 clinical trial?
NCT06681818 is sponsored by Englewood Hospital and Medical Center. The principal investigator is Cherif Boutros, MD at Englewood Hospital. The trial plans to enroll 125 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.